Close
Almac
Achema middle east

Press Releases

RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S

RedHill Biopharma Ltd, a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer announced that it has initiated promotion of Esomeprazole Strontium Delayed-Release (DR)...

Zavante Therapeutics Announce Agreement To Assess ZOLYD™ for Lower Respiratory Tract Infections With NIAID

Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, has signed a Clinical Trial Agreement with the National Institute of Allergy and Infectious Disease (NIAID) to evaluate Zavante’s investigational antibiotic...

Bioanalytical Laboratory Expansion at Its USA Headquarters Completed By BioAgilytix

Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has completed the expansion of the laboratory facility within its USA headquarters located in the Research Triangle area of North Carolina. ...

mProve Health and Greenphire Partner to Delivera First-of-its-Kind Patient Engagement Solution

mProve Health, a leading provider of mobile technologies for patient engagement and electronic clinical outcome assessments (eCOA), andGreenphire, the global leader in clinical payment automation, today announceda partnership to provide patients with real-time access to ClinCard payment detailsvia mProve’s...

FDA approves Mylotarg for treatment of acute myeloid leukemia

Pfizer Inc. announced that the U.S. Food and Drug Administration approved MYLOTARG™ (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory...

Aquavit Pharmaceuticals Adds New Patent To Its High-Tech Medical Portfolio

Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office has issued a patent for Apollo Technology, System and Method for Personalized Injection Treatment. This follows Aquavit's European Patent issued by the European Patent...

Clinerion releases revamped design with improved functionality for Patient Recruitment System.

Clinerion has redesigned the web application for Patient Recruitment System, creating a sleek, professional and intuitive new user interface with analytical capabilities. The system’s functionality and speed have been improved, further supporting decision-making for clinical trial...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »